See more speakers [icon type=”glyphicon glyphicon-chevron-right” color=”#b50024″]
[row]
[column lg=”4″ md=”12″ sm=”12″ xs=”12″ ]
[/column]
[column lg=”8″ md=”12″ sm=”12″ xs=”12″ ]
Institute:
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London
Website:
https://www.imperial.ac.uk/people/r.carhart-harris
Session:
Higher Brain Functions
Title of the talk:
TBD
[/column]
[/row]
[well type=””]
Research
The Psychedelic Research Group at Imperial focuses on two main research areas: 1) the action of psychedelic drugs in the brain, and 2) their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression. The group is lead by Dr Robin Carhart-Harris with oversight from Professor David Nutt. Robin Carhart-Harris has studied effects of LSD, psilocybin (magic mushrooms), and MDMA on the brain, conducting some of the first brain imaging studies of these drugs. Most recently he has been running a clinical trial looking at the potential of psilocybin to treat depression.
[/well]
[well type=””]
Selected Videos:
TED Talk – Psychedelics: Lifting the veil | Robin Carhart-Harris | TEDxWarwick
[/well]
[button style=”btn-danger btn-sm” icon=”glyphicon glyphicon-chevron-right” align=”right” type=”link” target=”false” title=”More speakers” link=”https://www.neurizons.uni-goettingen.de/programme/speakers-2018/”]